Stryker Corporation (SYK) was Initiated by SunTrust to “Buy”. SunTrust advised their investors in a research report released on Oct 14, 2016.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Stryker Corporation closed down -4.12 points or -3.50% at $113.73 with 14,33,448 shares getting traded on Tuesday. Post opening the session at $117.59, the shares hit an intraday low of $113.14 and an intraday high of $117.68 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
In a different news, on Oct 13, 2016, Ronda E Stryker (director) sold 12,000 shares at $113.41 per share price. According to the SEC, on Oct 13, 2016, Yin C Becker (VP, Comm. and Public Affairs) sold 12,000 shares at $114.03 per share price. On Aug 3, 2016, Roch Doliveux (director) purchased 46 shares at $115.39 per share price, according to the Form-4 filing with the securities and exchange commission.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.